Oral immunotherapy for peanut allergy 'increases risk'

There is 'significant uncertainty' over the experimental treatment's long-term safety and efficacy, say experts

Oral immunotherapy for peanut allergy greatly increases the risk of life-threatening anaphylactic reactions rather than preventing them as intended, a review of trials has found.